Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1998;98:1869-1874

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gunning, M. G.
Right arrow Articles by Underwood, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gunning, M. G.
Right arrow Articles by Underwood, S. R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

(Circulation. 1998;98:1869-1874.)
© 1998 American Heart Association, Inc.


Clinical Investigation and Reports

Comparison of 201Tl, 99mTc-Tetrofosmin, and Dobutamine Magnetic Resonance Imaging for Identifying Hibernating Myocardium

Mark G. Gunning, MRCP; Constantinos Anagnostopoulos, MD; Charles J. Knight, MA, MRCP; John Pepper, MChir, FRCS; Elisabeth D. Burman; Glyn Davies, PhD; Kim M. Fox, MD, FRCP; Dudley J. Pennell, MD, MRCP; Peter J. Ell, MD, FRCP; ; S. Richard Underwood, MD, FRCP

From the Departments of Cardiac Imaging, Cardiology, and Cardiac Surgery, Royal Brompton Hospital, and the Institute of Nuclear Medicine, University College London Medical School (P.J.E.), London, UK.

Correspondence to Dr Mark G. Gunning, MRI Unit, Royal Brompton Hospital, Sydney St, SW3 6NP, London, UK.

Background—Both radionuclide perfusion tracers and contractile response to dobutamine have been used to identify hibernating myocardium. The aim was to compare 201Tl (thallium) single photon emission CT (SPECT), 99mTc-tetrofosmin (tetrofosmin) SPECT, and dobutamine cine MRI for identifying regions of reversible myocardial dysfunction.

Methods and Results—Thirty patients with 3-vessel coronary artery disease and impaired left ventricular function (mean LVEF, 24.0%; SD, 8.3%) scheduled for coronary bypass grafting were recruited. All underwent rest/dobutamine stress (5 to 10 µg · kg-1 · min-1) cine MRI, stress/rest tetrofosmin SPECT, and stress/redistribution and separate-day rest/redistribution thallium SPECT before surgery. Stress/redistribution thallium SPECT and resting MRI were repeated after surgery. In a 9-segment model, SPECT images were scored visually for tracer uptake, which was also measured from a polar plot of myocardial counts. MRI was scored visually for endocardial motion, myocardial thickening, and thickness. Five patients died before follow-up, and 2 declined postoperative investigation. In the remaining 23 patients, mean LVEF increased from 24.0% (SD, 8.3%) to 29.7% (SD, 11.1%) (P<0.05). Of 207 segments analyzed, 145 had significantly abnormal wall motion before surgery, and 82 of these improved function after revascularization. The criteria for predicting recovery of severely hypokinetic segments on preoperative imaging were tracer uptake graded "moderately reduced" or better, or positive inotropic response on dobutamine MRI. Late-rest thallium images showed the highest sensitivity (76%), compared with stress-redistribution thallium (68%) and rest tetrofosmin (66%) (P<0.05). All 3 tracer techniques were nonspecific (44%, 51%, and 49%, respectively). Redistribution of thallium after the resting injection was insensitive (18%) but highly specific (83%). Inotropic response to dobutamine was also insensitive (50%) but specific (81%).

Conclusions—Radionuclide uptake is a sensitive but nonspecific predictor of myocardial functional recovery, whereas dobutamine MRI is specific but insensitive.


Key Words: magnetic resonance imaging • radioisotopes • surgery • perfusion




This article has been cited by other articles:


Home page
Br Med BullHome page
J. Stirrup, A. Maenhout, K. Wechalekar, and C. Anagnostopoulos
Radionuclide imaging in ischaemic heart failure
Br. Med. Bull., August 26, 2009; (2009) ldp029v1.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
T A M Kaandorp, H J Lamb, E E van der Wall, A de Roos, and J J Bax
Cardiovascular MR to access myocardial viability in chronic ischaemic LV dysfunction
Heart, October 1, 2005; 91(10): 1359 - 1365.
[Full Text] [PDF]


Home page
JNMHome page
A. Giorgetti, A. Pingitore, B. Favilli, A. Kusch, M. Lombardi, and P. Marzullo
Baseline/Postnitrate Tetrofosmin SPECT for Myocardial Viability Assessment in Patients with Postischemic Severe Left Ventricular Dysfunction: New Evidence from MRI
J. Nucl. Med., August 1, 2005; 46(8): 1285 - 1293.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
P. J. Slomka, D. Fieno, L. Thomson, J. D. Friedman, S. W. Hayes, G. Germano, and D. S. Berman
Automatic Detection and Size Quantification of Infarcts by Myocardial Perfusion SPECT: Clinical Validation by Delayed-Enhancement MRI
J. Nucl. Med., May 1, 2005; 46(5): 728 - 735.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
J J Bax, E E van der Wall, and M Harbinson
Radionuclide techniques for the assessment of myocardial viability and hibernation
Heart, August 1, 2004; 90(suppl_5): v26 - v33.
[Full Text] [PDF]


Home page
CirculationHome page
R. J. Kim and W. J. Manning
Viability Assessment by Delayed Enhancement Cardiovascular Magnetic Resonance: Will Low-Dose Dobutamine Dull the Shine?
Circulation, June 1, 2004; 109(21): 2476 - 2479.
[Full Text] [PDF]


Home page
Eur Heart JHome page
S.R. Underwood, J. J Bax, J. v. Dahl, M. Y Henein, A. C van Rossum, E. R Schwarz, J.-L. Vanoverschelde, E. E.v. d. Wall, and W. Wijns
Imaging techniques for the assessment of myocardial hibernation: Report of a Study Group of the European Society of Cardiology
Eur. Heart J., May 2, 2004; 25(10): 815 - 836.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Shan, G. Constantine, M. Sivananthan, and S. D. Flamm
Role of Cardiac Magnetic Resonance Imaging in the Assessment of Myocardial Viability
Circulation, March 23, 2004; 109(11): 1328 - 1334.
[Full Text] [PDF]


Home page
Eur Heart JHome page
A.F.L Schinkel, J.J Bax, M.L Geleijnse, E Boersma, A Elhendy, J.R.T.C Roelandt, and D Poldermans
Noninvasive evaluation of ischaemic heart disease: myocardial perfusion imaging or stress echocardiography?
Eur. Heart J., May 1, 2003; 24(9): 789 - 800.
[Full Text] [PDF]


Home page
JNMHome page
E. Tadamura, M. Mamede, S. Kubo, H. Toyoda, M. Yamamuro, H. Iida, N. Tamaki, K. Nishimura, M. Komeda, and J. Konishi
The Effect of Nitroglycerin on Myocardial Blood Flow in Various Segments Characterized by Rest-Redistribution Thallium SPECT
J. Nucl. Med., May 1, 2003; 44(5): 745 - 751.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
B. B. Chin, G. Esposito, and D. L. Kraitchman
Myocardial Contractile Reserve and Perfusion Defect Severity with Rest and Stress Dobutamine 99mTc-Sestamibi SPECT in Canine Stunning and Subendocardial Infarction
J. Nucl. Med., April 1, 2002; 43(4): 540 - 550.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. G. Gunning, R. R. Kaprielian, J. Pepper, D. J. Pennell, M. N. Sheppard, N. J. Severs, K. M. Fox, and S. R. Underwood
The histology of viable and hibernating myocardium in relation to imaging characteristics
J. Am. Coll. Cardiol., February 6, 2002; 39(3): 428 - 435.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H.-M. J. Siebelink, P. K. Blanksma, H. J. G. M. Crijns, J. J. Bax, A. J. van Boven, T. Kingma, D. A. Piers, J. Pruim, P. L. Jager, W. Vaalburg, et al.
No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: A prospective, randomized comparison of patients with suspicion of jeopardized myocardium
J. Am. Coll. Cardiol., January 1, 2001; 37(1): 81 - 88.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
R Schulz and G Heusch
Hibernating myocardium
Heart, December 1, 2000; 84(6): 587 - 594.
[Full Text]


Home page
Eur Heart JHome page
F.M Baer, P Theissen, J Crnac, M Schmidt, H.J Deutsch, U Sechtem, H Schicha, and E Erdmann
Head to head comparison of dobutamine-transoesophageal echocardiography and dobutamine-magnetic resonance imaging for the prediction of left ventricular functional recovery in patients with chronic coronary artery disease
Eur. Heart J., June 2, 2000; 21(12): 981 - 991.
[Abstract] [PDF]


Home page
HeartHome page
R J Trent, G D Waiter, G S Hillis, F I McKiddie, T W Redpath, and S Walton
Dobutamine magnetic resonance imaging as a predictor of myocardial functional recovery after revascularisation
Heart, January 1, 2000; 83(1): 40 - 46.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
J. N. Oshinski, H.-C. Han, D. N. Ku, and R. I. Pettigrew
Quantitative Prediction of Improvement in Cardiac Function after Revascularization with MR Imaging and Modeling: Initial Results
Radiology, November 1, 2001; 221(2): 515 - 522.
[Abstract] [Full Text] [PDF]